Among the dark genes, we found that patients with tumours with high expression of ARL6IP6 exhibited the shortest significant OS duration (OS = 57.07 months) compared to those with low gene expression (OS = 127.33 months; Fig 8C). This evidence concerns the gene ARL6IP6 and neoplasm.